This HTML5 document contains 126 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n4http://dx.doi.org/10.3816/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37442881
rdf:type
wikibase:Item
schema:description
scientific article published on August 2010 artigo científico научни чланак vetenskaplig artikel vědecký článek vedecký článok wetenschappelijk artikel wissenschaftlicher Artikel bilimsel makale articolo scientifico article científic article scientifique مقالة علمية نشرت في أغسطس 2010 artículu científicu espublizáu en 2010 videnskabelig artikel наукова стаття, опублікована в серпні 2010
p:P577
wds:Q37442881-7F44170C-9142-463B-AB2F-AC9B268B9BC2
wdt:P577
2010-08-01T00:00:00Z
p:P407
wds:Q37442881-64C163FC-8CE9-4A6B-9032-04942EA89222
wdt:P407
wd:Q1860
p:P2860
wds:Q37442881-2E927ABC-9D89-448B-80CF-48694CAC6004 wds:Q37442881-356A1B02-3925-4761-B6CB-301D6F09242F wds:Q37442881-0EC36D34-09D5-4F0D-A0A5-A7B2B9C8FC9C wds:Q37442881-BF70D29D-87D3-44A5-9690-6294D8703F06 wds:Q37442881-CAF8550B-71E9-47C3-B2C1-A15913A6E132 wds:Q37442881-ABEF10E7-F68B-4231-8C30-9EB95B74DA98 wds:Q37442881-AC0D6963-AD4D-4978-BB49-6CBB45DE59C6 wds:Q37442881-B0940D03-E063-486E-BE1E-82A2C29F9953 wds:Q37442881-AB57A577-6722-4440-A189-4C3BB01C5BED wds:Q37442881-AB763899-036D-4795-B9C5-1D627A1EB606 wds:Q37442881-9BC4C5B9-8DD6-49ED-BDE9-9757EACCEB62 wds:Q37442881-7FE97300-76A7-4D01-B8C8-F67593D2D7E3 wds:Q37442881-78269020-444A-4079-8CA9-EBF728565A11 wds:Q37442881-7DEBAAF4-D681-47FF-BF33-BAAC23A1465B wds:Q37442881-7ED1D0DD-A251-4518-9240-15B2BF5B938E wds:Q37442881-5B767569-0AC5-4A3E-B869-819C61BE86D0 wds:Q37442881-66302628-F25F-49E2-A29D-BC7A84D97FD9 wds:Q37442881-FC35973E-374C-4CD0-A43B-7A5D36893ADD wds:Q37442881-E7464477-D714-43A0-A1A3-FE86FD96D5A5 wds:Q37442881-E83A036C-9162-490E-8735-1B2359CF73FB
wdt:P2860
wd:Q56626150 wd:Q47672924 wd:Q37496425 wd:Q46246951 wd:Q27860693 wd:Q43607758 wd:Q41436820 wd:Q33369733 wd:Q79748462 wd:Q38474138 wd:Q40634050 wd:Q27824766 wd:Q42627458 wd:Q46227342 wd:Q29617440 wd:Q57578399 wd:Q29035867 wd:Q27824835 wd:Q40630247 wd:Q41454983
p:P2093
wds:Q37442881-DFD6E289-FAA5-45D5-8AD7-4DDDE63DA810 wds:Q37442881-E17FED6E-D304-4059-9FE7-A2525E0CFA70 wds:Q37442881-98D216DC-3FCA-4177-9D94-CA90DCCC3B51 wds:Q37442881-65C661DD-04E7-4954-8600-2B92C5220F1F wds:Q37442881-765F92B8-D5D5-4A96-BC74-749ED10E6762 wds:Q37442881-DC9E1CEF-EEA0-4B8F-BA6C-786B1AD864A7 wds:Q37442881-DECD0167-7486-4F80-AFC6-87529861B602 wds:Q37442881-D9A86A43-EF04-4F80-AF7D-1454FAA3C892 wds:Q37442881-59AEFB4F-0A84-4A4D-B78D-FFF895282EFA wds:Q37442881-15FC67C2-21F8-40C5-B11B-39A964D75927 wds:Q37442881-063C95F1-1867-4D44-98F8-BFE679D36CE6
wdt:P2093
Clifford A Hudis Adam M Brufsky Michael Danso Mansoor Saleh Andrew D Seidman Ariadne Bach Diana Lake Tiffany Traina Alison K Conlin Alicia Clawson Maura Dickler
rdfs:label
Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer. Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer. Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer.
skos:prefLabel
Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer. Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer. Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer.
schema:name
Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer. Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer. Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer.
p:P50
wds:Q37442881-A34884CF-9479-4498-9C06-3893D03E38BA
wdt:P50
wd:Q73445678
p:P1476
wds:Q37442881-476FB5D4-078B-405B-98A7-D48C04387830
wdt:P1476
Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer
p:P304
wds:Q37442881-379FBDD0-B7F4-4DAE-83DA-1C6FA4E96B06
wdt:P304
281-287
p:P31
wds:Q37442881-D4ABA028-1278-4B8E-AC1E-01B423AD2F7C
wdt:P31
wd:Q13442814
p:P921
wds:Q37442881-820979A2-933F-474F-90C8-2A9990DD3E41 wds:Q37442881-9F18A30B-7E95-44B4-8578-7FB2136311B8 wds:Q37442881-29D84D2A-04C2-4C42-B321-0543C9251EFC wds:Q37442881-BDD9C16C-EA6A-41CA-A845-37F6BC3BD29E wds:Q37442881-BF1BCDEB-D9FF-4AED-8140-2EB6AC625E21 wds:Q37442881-C977424C-D8E4-4AE5-957D-6D79D156EF19
wdt:P921
wd:Q412616 wd:Q423762 wd:Q61643320 wd:Q415588 wd:Q42824440 wd:Q61231
p:P698
wds:Q37442881-3C428650-4701-44E8-AF23-D2EBA9E48CEB
wdtn:P698
n12:20705560
wdt:P698
20705560
p:P1433
wds:Q37442881-AB5212A0-BE30-4FDC-A807-70EBE2A653E1
wdt:P1433
wd:Q332245
p:P433
wds:Q37442881-94806E2B-C1CD-4CFC-869D-2AD798824A09
p:P478
wds:Q37442881-90FEC601-A945-4861-8E51-687D7DF457BD
wdt:P433
4
wdt:P478
10
p:P356
wds:Q37442881-0AA69C0E-7DE5-4DD2-A435-D5B41323D42F
wdtn:P356
n4:CBC.2010.N.036
wdt:P356
10.3816/CBC.2010.N.036
p:P932
wds:Q37442881-46B08415-5126-4F30-9B68-4887007CAD81
wdt:P932
3883128